The design and rationale of the Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of

Junran J Peng1, Navid Saleh1, Thomas M Roston1

  • 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Insights

Opportunistic genetic testing for familial hypercholesterolemia (FH) in acute coronary syndrome (ACS) patients can increase FH diagnosis. This approach aims to improve outcomes for this common inherited cardiovascular disorder.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Clinical Trials

Background:

  • Familial hypercholesterolemia (FH) is a prevalent inherited disorder causing high LDL-C and premature cardiovascular disease.
  • Despite its prevalence, FH remains significantly underdiagnosed and undertreated globally.
  • Early diagnosis and treatment are crucial for preventing atherosclerotic cardiovascular disease (ASCVD) events.

Purpose of the Study:

  • To evaluate the effectiveness of opportunistic genetic testing for FH in hospitalized acute coronary syndrome (ACS) patients.
  • To determine if genetic testing increases FH diagnosis rates and improves lipid-lowering therapy intensification.
  • To assess the impact of genetic testing on achieving lipid targets and reducing LDL-C levels post-ACS.

Main Methods:

  • The ACCURATE study is a non-randomized, controlled trial involving patients under 60 admitted with ACS and elevated LDL-C.
  • A control group receives standard care, while an intervention group undergoes genetic testing for FH during hospitalization.
  • Outcomes include new FH diagnoses, lipid-lowering therapy intensification, LDL-C levels, and guideline target achievement over 12 months.

Main Results:

  • Primary endpoint: Number of patients with a new FH diagnosis.
  • Secondary endpoints: Proportion of patients with intensified lipid-lowering therapy, lowest achieved LDL-C, and proportion reaching lipid targets within 12 months post-ACS.

Conclusions:

  • The ACCURATE study is the first clinical trial testing genetic testing for FH in the acute cardiac care setting.
  • Findings are expected to guide strategies for improving FH diagnosis and treatment.
  • This research may lead to better management of inherited hypercholesterolemia and reduce ASCVD risk.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
323
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
720
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
321